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Gauging circadian variation in ketamine metabolism by real-time 
breath analysis 
P. Martinez-Lozano Sinues,a  M. Kohler,b  S. A. Brown,c  R. Zenobi a and R. Dallmann‡,*,c
Time-of-day of drug application is an important factor in 
maximizing efficacy and minimizing toxicity. Real-time in vivo mass 
spectrometric breath analysis of mice was deployed to investigate 
time-of-day variation in ketamine metabolism. Different 
production rates of ketamine metabolites, including the recently 
described anti-depressant hydroxynorketamine, were found at 
opposite circadian phases. Thus, breath analysis has potential as a 
rapid and 3Rs (Replacement, Reduction and Refinement) 
conforming screening method to estimate time-dependence of 
drug metabolism.  
Mammalian physiology and behaviour are modulated by 
biological clocks preparing and adapting the organism to the 
24 h cycles of day and night in the environment. These so-called 
circadian clocks are present in virtually all mammalian cells and 
modulate not only levels of endogenous metabolites in mice1 
and human beings,2 ,but also the metabolism of xenobiotics.3. 
For example, the hepatocyte clock is critically important for 
daily variation in CYP P450 dependent drug metabolism.4. 
Chronotherapy aims to capitalize on these rhythms by 
maximizing drug efficacy and minimizing toxicity through 
adjusting dosing-time.3. As a result, chronobiology is playing a 
growing role in drug development to address the optimization 
optimisation of the most beneficial time to administer drugs.5. 
However, studying the impact of time-of-day of dosing in drug 
metabolism represents a challenge in the already congested 
pipeline of typical drug development workflows. Thus, the 
development of novel methods to rapidly assess timing in drug 
development is of high interest.  
The use of sensitive gas-trace analysers to measure metabolites 
emitted by unrestrained mice is an attractive approach to  study 
in vivo metabolism.6. Recently, we have shown that secondary 
electrospray ionization (SESI)7 coupled with high resolution 
mass spectrometry (HRMS) provides sufficient sensitivity and 
selectivity to track in vivo and in real time the metabolism of 
drugs in mice breath, which correlate with blood levels.8. The 
proposed method enables capturing pharmacokinetic profiles 
of injected drugs in real time with a time resolution of 10 s from 
a single mouse in a comparably stressless procedure (Fig. S1, 
ESI†). Here, we show that the SESI-HRMS technique can also 
contribute to rapidly assessing the impact of dosing time drug 
metabolism. In view of recent findings suggesting that 
hydroxynorketamine (HNK), a metabolite of ketamine, is crucial 
for ketamine’s immediate anti-depressant effects but lacks the 
psychotic side-effects of its parent compound,9, we payed paid 
particular attention to the response of this metabolite.  
The abundance of ketamine as well as its major metabolites was 
tracked in the breath of adult male C57BL/6J congenic (referred 
to as wild-type, WT) mice immediately after ketamine injection 
(30 mg/kg). Fig. 1 normalshows the real-time pharmacokinetic 
profiles of HNK either during the rest phase (ZT22-2, early 
morning), or early active phase (eveningZT10-14, early night) for 
two individuals from each phasein two individuals each. Of 
note, mice from morning and evening groups were measured in 
alternation to avoid potential confounding effects due to carry-
over and instrument drifts with time. The time-to-peak for this 
particular dose was found to be around 25-30 min, which is fully 
consistent with our previous results.8. In contrast, however, a 
clear difference in ketamine metabolism was observed. Evening 
injection of ketamine leads to two-fold higher HNK levels than 
in the morning. The same trend was observed for further 
ketamine metabolites (i.e., norketamine, hydroxyketamine, and 
dehydronorketamine; Fig S2, ESI†). 
The results shown in Fig. 1 suggest that ketamine metabolism is 
dependent on time-of-day. This is in line with previous 
observations on the time-of day variation of the hypnotic 
effects (“sleep time”) of ketamine in rodents;10; early morning 
injection of ketamine led to longer sleep time compared to 
evening injection. In line with these results, we found higher 
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levels of ketamine metabolites after evening dosing suggesting 
faster ketamine metabolism in the evening and therefore 
shorter sleep time. 
 
 
Fig. 1. Different ketamine metabolism depending on internal time. The traces correspond 
to exhaled hydroxynorketamine (structure displayedHNK), norketamine (NK),  
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hydroxyketamine (HKT) and dehydronorketamine (DHNKT) for four wild-type mice: two 
of them measured in the evening and the other two in the opposite circadian phase. 
Black dots represent raw data (5 s time resolution) and red traces are smoothed curves. 
Ketamine is metabolized by liver microsomal cytochrome (CYP) 
P450,11, which are under circadian control.12. However, it is 
unclear whether the daily variation in its hypnotic effect is 
dependent on circadian control of drug metabolism or, as 
hypothesised elsewhere, the availability of its receptor target in 
the brain.10a. To confirm whether the liver clock is necessary to 
create the time-of-day effect (Fig. 1), we repeated the our 
measurements in wild-type (WT) and congenic  in addition we 
included mice specifically lacking a functional liver clock, i.e. 
mice with liver-specific deletion of the core clock gene Bmal1 
((referred to as knock-out, KO). Figure. 2a shows the time traces 
of HNK in twowild-type and knock-out mice either with or 
without liver clock injected and measured either in the morning 
or evening. Consistent with Fig. 1, we observed a clear diurnal 
difference in drug metabolism in wild-type mice depending on 
the time of administration. In contrast, this difference was 
absent in liver clock deficient miceKO mice did not show 
injection time dependent differences indicating a loss of 
circadian control of metabolism. In fact, The same results are 
observed for the more abundant norketamine metabolite 
(Fig. 2b).  Ketamine metabolism in knock-outliver specific 
BMAL1-deficient mice wshowedas similar to the lower morning 
levels in wild-type at all timesketamine metabolism and this 
suggests CYP P450 activity at all times, which has also been 
observed after liver specific deletion of its binding partner 
CLOCK. In line with previous studies4, this suggests lower 
CYP P450 activity in knock-out mice.4. The difference between 
WT and KO is even morealso clear for the more abundant 
norketamine metabolite (Fig. S32b). Thus, we conclude that the 
circadian metabolism of ketamine is likely modulated by the 
liver clock. Of note, our data do not exclude that the variation 
in the hypnotic effects of ketamine are also due to NMDA 
receptor availability rather than metabolism alone.10a. 
One of the main advantages of our method is that hundreds of 
exhaled metabolites are monitored simultaneously. Thus, apart 
from tracking the pharmacokinetic profiles of known xenobiotic 
metabolites (e.g., HNK), it offers an opportunity to explore – in 
an untargeted fashion – endogenous metabolites either altered 
as a result of drug administration or representing the 
physiological state of the animal. A closer inspection of the mass 
spectra revealed that, apart from the noted differences 
observed for ketamine and its main metabolites, a set of 
compounds showed a marked variation with time-of-day of 
drug administration in wild-type mice. For example, Figureg. 3 
shows the the time traces of one compound example 
compound displaying an inverse time-of-day dependent 
variation in abundance measured when measured at the same 
times as the data mice presented in Fig. 1. By HRMS, this 
compound was assigned a molecular formula of The high mass 
accuracy and resolution of the mass spectrometer enabled 
assigning the molecular formula for this compound as 
C16H28N2O2.  
 
Fig. 2. Hydroxynorketamine (a) and norketamine (b) breath levels for WT measured in 
the evening (upper-left), WT measured in the morning (upper-right), KO measured in the 
evening (bottom-left) and KO measured in the morning (bottom-right). Each curve per 
metabolite corresponds to one mouse (n = 8). The data suggests that the time-
dependent sensitivity to ketamine is dictated by the liver clock. Black dots represent raw 
data and red traces the corresponding smoothed curves 
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In total, we observed 24 compounds not reported, to the best 
of our knowledge, as ketamine metabolites that showed daily 
variations similar or in anti-phase to that of ketamine. Figure.  3 
provides an overview of the temporal evolution variation inof 
these compounds. It shows the heatmap and hierarchical 
cluster analysis for these 24 compounds found to have a distinct 
behaviour depending on the circadian phasewith diurnal 
regulation. The Ccluster analysis revealed 11 compounds 
increased in the morning mice and 13 compounds relatively 
increased in evening mice. Interestingly, among the compounds 
relatively elevated in in the mice injected with ketamine in the 
morning, we found a clear series of compounds clustering 
closely together. For example, C16H28N2O2, C21H38N2O2, 
C21H38N2O3 and C17H30N2O3. Table S1 lists the measured 
accurate masses and Fig.ure  S2 shows some representative 
mass spectra.: C6H6N2O2, C15H26N2O2, C16H26N2O2, C16H28N2O2, 
C16H30N2O2, C21H38N2O2, C17H30N2O3 and C21H38N2O3. Similarly, 
families of metabolites (e.g., aminoacids metabolism), have 
been shown to be altered shortly after ketamine 
administration.13. However, while the molecular formulae in 
our study can be assigned with high confidence, positive 
identification of these altered metabolites remains to be 
accomplished.   
 
 
 
Fig. 3 The levels of other metabolites apart from those showed in Fig. 1 and S2 also 
showed a circadian behaviour. The heatmap provides an overview of 24 compounds 
found to have a distinct behaviour depending on time-of-dose. On the top the actual 
(smmoothed) time traces of one such compound with molecular formula C16H28N2O2 are 
shown. In contrast with hydroxyketamine, this compound was produced in higher 
abundance in mice injected in the morning. Note also the series of compounds with 
closely related molecular formulas showing similar responses. 
In conclusion, SESI-HRMS has potential not only to assess 
pharmacokinetic profiles by analysis of exhaled breath in mice, 
but also to further investigate the impact of time-toof-day on 
drug behaviour, i.e., pharmacokinetics and metabolism. Our 
results suggest that ketamine does exhibit circadian variation in 
metabolism, which leadingis especially apparent in to the 
widely differing levels of metabolites observed at different 
circadian times. Furthermore, these differences are liver clock 
dependent, because animals that lack a functional hepatocyte 
clock lack this variation. Interestingly, hydroxynorketamine has 
recently been shown to have an immediate anti-depressant 
effect like ketamine but without any of the psychotic side-
effects.9. Our data suggest that time-of-dosing should be 
considered in its future clinical development. In addition, 24 
other unidentified endogenous metabolites showed a marked 
circadian response. Our method shows potential as a rapid and 
animal-friendly screening method, for example, to optimisze 
chronotherapeutic regimes and monitor drug and metabolite 
levels in multiple dosing schedules in a single animal. It 
significantly advances two of the 3Rs14, i.e., refinement because 
the blood sampling is circumvented and reduction because 
multiple measurements can be taken from one animal.  
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